BenevolentAI Investor Day Presentation Deck
Our Precision Medicine approaches are applied to multiple
stages of our pipeline and can support repurposing activities
Precision Medicine
enabled Target ID
Target
Identification
Hyp Gen &
Hyp Val
Hit ID &
Expansion
Discovery
Lead Op
Candidate
Seeking
Indication mapping
Preclinical
Repurposing a target or drug (approved or in development)
through the identification of additional disease indications
Address additional unmet need
Maximise the value of a target or drug programme
Identifying key patient cohorts and responders for drugs
Optimise clinical development
Increase probability of success
Improve outcomes for patients
Development
Phase I
Phase II
Phase III
Approval
& Launch
Identification of patient
cohorts & responders
Phase IV
Additional
indications
Commercial
& Lifecycle
Optimised trial
design & patient
outcomes for
each indication
Benevolent 63View entire presentation